2020 HERO Appendix C: Human Health Countermeasures and Space Radiation Topics

OVERVIEW
Validity Period: July 31, 2020 – July 30, 2021



REFER TO APPENDICES FOR SPECIFIC OPPORTUNITY DUE DATES
For Grants.gov reference the Catalog of Federal Domestic Assistance (CFDA) Number: 43.003
Page 2 of 66
Human Exploration Research Opportunities
Table of Contents A. EXECUTIVE SUMMARY .............................................................................................................................. 5 B. HUMAN RESEARCH PROGRAM ................................................................................................................ 7 1. BACKGROUND ................................................................................................................................. 7 2. GOAL AND SPECIFIC OBJECTIVES ..................................................................................................... 8 C. SOLICITATION ............................................................................................................................................. 9 1. PROPOSAL SOLICITATION PROCESS .................................................................................................. 9 2. SOLICITED RESEARCH OPPORTUNITIES ............................................................................................ 9 3. EDUCATION AND PUBLIC OUTREACH ............................................................................................. 10 4. VERTEBRATE ANIMAL SCIENTIFIC REVIEW .................................................................................... 10 5. SAMPLE SIZE SPECIFICATION GUIDELINES FOR HRP RESEARCH STUDIES ...................................... 10 6. NASA SAFETY POLICY .................................................................................................................. 11 7. HUMAN GENETIC RESEARCH ......................................................................................................... 11 8. CONSIDERATION OF SEX AS A BIOLOGICAL VARIABLE ................................................................... 12 9. AVAILABILITY OF FUNDS FOR AWARD ........................................................................................... 12 10. ADDITIONAL FUNDING RESTRICTIONS ......................................................................................... 12 11. AWARD INFORMATION................................................................................................................. 12 12. DIVERSITY AND INCLUSION ......................................................................................................... 13 D. ELIGIBILITY INFORMATION .................................................................................................................. 14 1. ELIGIBILITY OF APPLICANTS .......................................................................................................... 14 2. GUIDELINES FOR INTERNATIONAL PARTICIPATION ..........................................